3-chloro-L-tyrosine has been researched along with Atherogenesis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atkins, KB; Brosius, FC; Byun, J; Mathew, AV; Pennathur, S; Zeng, L | 1 |
| Beubler, E; Fauler, G; Gauster, M; Heinemann, A; Holzer, M; Koefeler, H; Marsche, G; Pfeifer, T; Schuligoi, R; Stiegler, P; Wadsack, C | 1 |
| Heinecke, JW; Pennathur, S; Shao, B | 1 |
| Chai, H; Chen, C; Lin, PH; Lumsden, AB; Mohiuddin, I; Yao, Q | 1 |
1 review(s) available for 3-chloro-L-tyrosine and Atherogenesis
| Article | Year |
|---|---|
Nitrotyrosine and chlorotyrosine: clinical significance and biological functions in the vascular system.
Topics: Animals; Atherosclerosis; Endothelium, Vascular; Humans; Oxidative Stress; Tyrosine; Vasculitis | 2006 |
3 other study(ies) available for 3-chloro-L-tyrosine and Atherogenesis
| Article | Year |
|---|---|
Myeloperoxidase-derived oxidants damage artery wall proteins in an animal model of chronic kidney disease-accelerated atherosclerosis.
Topics: Animals; Aorta; Atherosclerosis; Blood Urea Nitrogen; Creatinine; Diet, Fat-Restricted; Diet, High-Fat; Dietary Fats; Disease Models, Animal; Disease Progression; Kidney Failure, Chronic; Kidney Function Tests; Lipids; Lipoproteins; Macrophages; Male; Mice; Mice, Knockout; Muscle Proteins; Nephrectomy; Oxidants; Oxidative Stress; Parathyroid Hormone; Peroxidase; Receptors, LDL; Tyrosine; Vasodilation | 2018 |
Protein carbamylation renders high-density lipoprotein dysfunctional.
Topics: Adult; Aged; Apolipoprotein A-I; Atherosclerosis; CD36 Antigens; Cells, Cultured; Cholesterol; Cyanates; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Macrophages; Mass Spectrometry; Middle Aged; Oxidation-Reduction; Peroxidase; Protein Processing, Post-Translational; Tyrosine | 2011 |
Myeloperoxidase targets apolipoprotein A-I, the major high density lipoprotein protein, for site-specific oxidation in human atherosclerotic lesions.
Topics: Apolipoprotein A-I; Atherosclerosis; Halogenation; Humans; Hypochlorous Acid; Lipoproteins, HDL; Nitrogen; Oxidation-Reduction; Oxidative Stress; Peroxidase; Protein Processing, Post-Translational; Tyrosine | 2012 |